Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 489

1.
2.

Interaction of fluvastatin with the liver-specific Na+ -dependent taurocholate cotransporting polypeptide (NTCP).

Greupink R, Dillen L, Monshouwer M, Huisman MT, Russel FG.

Eur J Pharm Sci. 2011 Nov 20;44(4):487-96. doi: 10.1016/j.ejps.2011.09.009. Epub 2011 Sep 16.

PMID:
21945488
3.

Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3.

Gui C, Miao Y, Thompson L, Wahlgren B, Mock M, Stieger B, Hagenbuch B.

Eur J Pharmacol. 2008 Apr 14;584(1):57-65. doi: 10.1016/j.ejphar.2008.01.042. Epub 2008 Feb 8.

4.

Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.

Bachmakov I, Glaeser H, Fromm MF, König J.

Diabetes. 2008 Jun;57(6):1463-9. doi: 10.2337/db07-1515. Epub 2008 Feb 26.

5.

Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.

Gozalpour E, Greupink R, Wortelboer HM, Bilos A, Schreurs M, Russel FG, Koenderink JB.

Mol Pharm. 2014 Jun 2;11(6):1844-55. doi: 10.1021/mp400699p. Epub 2014 May 6.

PMID:
24754247
6.

Isolation of modulators of the liver-specific organic anion-transporting polypeptides (OATPs) 1B1 and 1B3 from Rollinia emarginata Schlecht (Annonaceae).

Roth M, Araya JJ, Timmermann BN, Hagenbuch B.

J Pharmacol Exp Ther. 2011 Nov;339(2):624-32. doi: 10.1124/jpet.111.184564. Epub 2011 Aug 16.

7.

Drug-drug interaction between pitavastatin and various drugs via OATP1B1.

Hirano M, Maeda K, Shitara Y, Sugiyama Y.

Drug Metab Dispos. 2006 Jul;34(7):1229-36. Epub 2006 Apr 4.

8.

Gemfibrozil and its glucuronide inhibit the hepatic uptake of pravastatin mediated by OATP1B1.

Nakagomi-Hagihara R, Nakai D, Tokui T, Abe T, Ikeda T.

Xenobiotica. 2007 May;37(5):474-86.

PMID:
17523051
9.

Expression and transport function of drug uptake transporters in differentiated HepaRG cells.

Kotani N, Maeda K, Debori Y, Camus S, Li R, Chesne C, Sugiyama Y.

Mol Pharm. 2012 Dec 3;9(12):3434-41. doi: 10.1021/mp300171p. Epub 2012 Nov 6.

PMID:
22897388
10.

Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions.

Izumi S, Nozaki Y, Maeda K, Komori T, Takenaka O, Kusuhara H, Sugiyama Y.

Drug Metab Dispos. 2015 Feb;43(2):235-47. doi: 10.1124/dmd.114.059105. Epub 2014 Nov 20.

11.

Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans.

Ishiguro N, Maeda K, Kishimoto W, Saito A, Harada A, Ebner T, Roth W, Igarashi T, Sugiyama Y.

Drug Metab Dispos. 2006 Jul;34(7):1109-15. Epub 2006 Apr 12.

12.
13.

Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.

Kindla J, Müller F, Mieth M, Fromm MF, König J.

Drug Metab Dispos. 2011 Jun;39(6):1047-53. doi: 10.1124/dmd.110.037622. Epub 2011 Mar 9.

14.

The eighth and ninth transmembrane domains in organic anion transporting polypeptide 1B1 affect the transport kinetics of estrone-3-sulfate and estradiol-17beta-D-glucuronide.

Miyagawa M, Maeda K, Aoyama A, Sugiyama Y.

J Pharmacol Exp Ther. 2009 May;329(2):551-7. doi: 10.1124/jpet.108.148411. Epub 2009 Feb 24.

15.

Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.

Kunze A, Huwyler J, Camenisch G, Poller B.

Drug Metab Dispos. 2014 Sep;42(9):1514-21. doi: 10.1124/dmd.114.058412. Epub 2014 Jul 2.

16.

Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3.

De Bruyn T, Fattah S, Stieger B, Augustijns P, Annaert P.

J Pharm Sci. 2011 Nov;100(11):5018-30. doi: 10.1002/jps.22694. Epub 2011 Aug 11.

PMID:
21837650
17.

Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions.

Sharma P, Holmes VE, Elsby R, Lambert C, Surry D.

Xenobiotica. 2010 Jan;40(1):24-37. doi: 10.3109/00498250903351013.

PMID:
19919292
18.

Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1.

Annaert P, Ye ZW, Stieger B, Augustijns P.

Xenobiotica. 2010 Mar;40(3):163-76. doi: 10.3109/00498250903509375.

PMID:
20102298
19.

Further characterization of the electrogenicity and pH sensitivity of the human organic anion-transporting polypeptides OATP1B1 and OATP1B3.

Martinez-Becerra P, Briz O, Romero MR, Macias RI, Perez MJ, Sancho-Mateo C, Lostao MP, Fernandez-Abalos JM, Marin JJ.

Mol Pharmacol. 2011 Mar;79(3):596-607. doi: 10.1124/mol.110.069971. Epub 2010 Dec 20.

20.

Contribution of organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 to hepatic uptake of nateglinide, and the prediction of drug-drug interactions via these transporters.

Takanohashi T, Kubo S, Arisaka H, Shinkai K, Ubukata K.

J Pharm Pharmacol. 2012 Feb;64(2):199-206. doi: 10.1111/j.2042-7158.2011.01389.x. Epub 2011 Nov 10.

PMID:
22221095

Supplemental Content

Support Center